Three Events in One

Bringing together industry leaders from across antibodies, immunotherapy and biosimilars. Hundreds of hours of content, coming to you! 



The Americas Antibody Congress is America's best space for discussing topics such as protein engineering, bispecifics and mAbs.




The World Immunotherapy Congress is your place to hear from industry leaders from companies such as Novartis, Roche and GSK. Join us in 2021 to cover themes such as Cell & Gene Therapy, Immune Check inhibitors and AI in oncology.



Biosimilars are making their mark within the pharma industry and we are bringing together leaders to share on topics such as sustainability, innovation and biobetters and patient and physician engagement.



2021 Congress Tracks

AI and Machine Learning in Oncology and Biomarkers
Antibodies in Immunotherapy
Armed Antibodies
Biosimilar Development, Manufacturing and Analysis
Biosimilars in Healthcare Policy
Checkpoint Inhibitors
Clinical Trials
CMC, Developability and Manufacturability
Commercialization and Market Access
Commercialization of Biosimilars and Sustainability of the Industry
New Technology in Screening and Analytics for Antibody Proteins
Non-Oncology Immunotherapy
Novel Indications for Therapeutic Antibodies
Oncolytic Viruses
The Clinical Environment and Real-world Evidence
Tumor Microenvironment
Value and affordability of Biosimilars

Sign Up For Event Updates

Sign Up for Event Updates




Track content to suit your day to day role

Specific sessions across all four events on discovery, development, clinical trials, market access strategies, IP and legal considerations, manufacturing, containment, safety, efficacy and more. With up to 18 tracks over two days (plus a pre-conference workshop day) there’s something for everyone working within biologics.



Scientific poster session

Discuss your work with experts during our poster networking session. Posters will be presented from various industries including academia, big pharma, solution providers and biotechs.



Technology showcase

A targeted session exploring the most innovative technologies being developed for biologic engineering and development.


Fantastic networking

Over 800 antibody, immunotherapy, biosimilar and clinical trial experts in one room, offering you the best chance to collaborate, partner and develop business.



Representation from executive level big pharma and biotech

A large number of C-level representatives from big pharma and biotech confirmed on the speaker faculty this year. We can guarantee that you will have many opportunities to learn from, and network with, key stakeholders from all across the biologics industry.



Leading academic and regulatory experts from leading institutions

With 20% of our speaker faculty being made up of some of the world’s leading academics, and chief regulators, hear the latest research and regulatory updates first hand.



Festibval of Biologics USA


There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.